Timothy Hohman
Family · Mc Murray, PANPI 1063768810
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 208 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 35.7% of the total. Reporting peaked in 2021 at $2,062 and has fallen 94.5% since, to $114 in 2024. Among family clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 208 payments — averaging $16.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Pfizer$312
- Amgen$309
- Novo Nordisk$185
- Biohaven Pharmaceuticals, Inc.$158
- Sunovion Pharmaceuticals Inc.$124
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,424100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 66 | $1,221 |
| Pfizer | 18 | $312 |
| Amgen | 24 | $309 |
| Novo Nordisk | 13 | $185 |
| Biohaven Pharmaceuticals, Inc. | 11 | $158 |
| Sunovion Pharmaceuticals Inc. | 8 | $124 |
| Daiichi Sankyo Inc. | 7 | $123 |
| Boehringer Ingelheim | 7 | $113 |
| Lilly USA, LLC | 4 | $113 |
| Amarin Pharma, Inc. | 5 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $66 |
| Bayer | 4 | $64 |
| UCB, Inc. | 2 | $61 |
| Currax Pharmaceuticals LLC | 4 | $57 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| Teva Pharmaceuticals USA, Inc. | 4 | $55 |
| AstraZeneca | 4 | $55 |
| Abbott | 3 | $49 |
| E.r. Squibb & Sons, L.L.C. | 3 | $42 |
| Astellas Pharma US Inc | 2 | $39 |
| GSK | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $32 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Genentech USA, Inc. | 3 | $15 |
| Redhill Biopharma Inc. | 1 | $12 |
| Nestle Healthcare Nutrition Inc. | 1 | $11 |
How this compares
$3,424 in reported general payments places this provider in the 90th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 14 | $121 |
Paid to pharmacies, not to this prescriber.
Other family in Mc Murray
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
- Patricia HabdasPittsburgh$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.